Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study
Patients with PUD are more likely to develop T2DM. Nevertheless, patients receiving anti-PUD medications have a lower incidence of T2DM.
Authors
- Wookjin Lee (ORCID: https://orcid.org/0000-0002-1907-1111)
- Yun-Ping Lim (ORCID: https://orcid.org/0000-0001-9312-048X)
- Yi‐Jen Fang
- Ni Tien
- Chi‐Hua Chen (ORCID: https://orcid.org/0000-0002-3547-7584)
- Cheng‐Li Lin (ORCID: https://orcid.org/0000-0002-7315-7709)
- Bang‐Jau You
- Fuu Jen Tsai
- Hui‐Hsia Hsieh (ORCID: https://orcid.org/0000-0002-0874-195X)
Institutions
- Asia University (TW)
- National Chung Hsing University (TW)
- China Medical University (TW)
- Taipei Tzu Chi Hospital (TW)
- Chang Bing Show Chwan Memorial Hospital (TW)
- China Medical University Hospital (TW)
Publication Details
- Journal
- Therapeutic Advances in Endocrinology and Metabolism
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1177/20420188251323945
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Medical University Hospital
- Buddhist Tzu Chi Medical Foundation
- Chang Bing Show Chwan Memorial Hospital